US health care reform team emerges after Daschle setback, biogenerics promised
The new federal administration of President Barack Obama is putting together the team it hopes will deliver a major health care reform package, following the setback of former US Senator Tom Daschle's failed nomination as Secretary of Health and Human Services (Marketletter February 9) over tax evasion claims. The new choice of HHS Secretary is Governor Kathleen Sebelius (Democrat, Kansas), who was widely rumored to be the then presidential candidate's most favored female choice for running mate shortly before the Democratic convention last year.
The White House Office for Health Reform, in an echo to a position once held by previous Democratic Pres Bill Clinton's wife in 1993, will be run by Nancy-Ann De-Parle, who then assisted Hillary Clinton (the new Secretary of State), the then architect of health care reform.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze